Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

Background The benefit of low‐density lipoprotein cholesterol (LDL‐C) levels in chronic kidney disease populations remains unclear. This study evaluated the cardiovascular and renal outcomes in patients with stage 3 chronic kidney disease with different LDL‐C levels during statin treatment. Methods...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Chieh‐Li Yen, Pei‐Chun Fan, Cheng‐Chia Lee, Jia‐Jin Chen, George Kuo, Yi‐Ran Tu, Pao‐Hsien Chu, Hsiang‐Hao Hsu, Ya‐Chung Tian, Chih‐Hsiang Chang
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Wiley 2022-10-01
Sarja:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Aiheet:
cardiovascular disease
chronic kidney disease
low‐density lipoprotein cholesterol
statin
stroke
Linkit:https://www.ahajournals.org/doi/10.1161/JAHA.122.027516

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.027516

Samankaltaisia teoksia